BioWorld

Aug. 22, 2011

View Archived Issues

Macro Woes Could Impact Biotech Financing, M&A

The economic situation over the last month or so "reminds a lot of people of 2008 and I can understand why," said Andy Busch, global currency and public policy strategist for BMO Capital Markets, during a recent conference call. Read More

New Use for Cash? Amgen Gives NPS Royalty Advance

Read More

Up-Front Milestone Balance Shifting in Biotechs' Favor

Read More

Money Raised Year to Date

Read More

Money Raised By Biotech in 2011

Read More

Week in Review

Read More

Word on the Street

Read More

Week in Washington

Read More

Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: March 1 - August 19, 2011

Read More

Stock Gainers and Losers For The Week

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More